Physician profile

Taylor Robert Burnham

Physical Medicine & Rehabilitation · Salt Lake City, UT

NPI 1841647377

$6,634.73

in general payments reported to CMS, 2019-2025

5 companies · none reported in 2025

See the full distribution for Physical Medicine & Rehabilitation

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$839.80
Food and Beverage$368.07

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $5,598.75 2020-2024 Intracept
Avanos Medical $839.80 2023 Generator
Spr Therapeutics, INC $111.96 2021-2023 Sprint Pns System
Stryker Corporation $69.14 2022-2023 Spinejack
Relievant Medsystems, INC. $15.08 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Taylor Robert Burnham

$6,634.73

in general payments reported 2019-2025

Years
2020-2024
Top company
Boston Scientific Corporation

https://glasscript.com/doctor/2740300/taylor-robert-burnham

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.